Alejandro Lopezi under the direction of Dr. Leslie Morrow successfully defended his dissertation on January 31, 2025 and received his PhD!
Program: Biochemistry and Biophysics
The title of his dissertation was “Novel Inhibitory Sites of [3α,5α]3-hydroxypregnan-20-one on Toll-like Receptor 4 Neuroimmune Signaling”